Positive topline results from phase 2 recurrent ovarian cancer trial
Rare oral cancer has distinct genetic profile
New tool decodes structures and motifs of RNA
Elite immune cells lead fight against multiple myeloma
HanchorBio receives FDA Orphan Drug Designation for gastric cancer drug
Collaboration to develop novel therapies for neutrophil-derived inflammatory diseases
Kainova Therapeutics raises C$32m to develop immuno-oncology and inflammation therapies
AmacaThera named Life Sciences Ontario Emerging Company of the Year
Syngene and Johns Hopkins University to advance early-stage drug discovery
New model to study colorectal cancer
Creating a new option for treating diabetic retinopathy
SPT Labtech and BellBrook Labs introduce high-throughput screening platform for cancer research